MINING

The Boulle Mining Group (''BMG'') is a division of the Jean Boulle Group which over the years has discovered some of the largest mineral resources projects in the world.

MEDTECH

Jean Boulle Medtech Ltd. is active in a wide range of pioneering and lifesaving medical technologies

THERAPEUTICS

Boulle Therapeutics identifies, invests in, and supports innovations that have the potential to save lives and improve the quality of life for large numbers of people

AGRICULTURE

The Jean Boulle Group's Indian Ocean Fields Ltd. is one of the largest shareholders of Omnicane Limited, a leading producer of sugarcane and power generation in Mauritius

LUXURY PRODUCTS

Jean Boulle Luxury has developed a proprietary diamond coating technique to transform natural gem diamonds into a high quality coating that gives a brilliant diamond finish to almost any surface.

A HISTORY OF GLOBAL SOLUTIONS

The Jean Boulle Group acquires promising assets and projects and optimizes their structure, management and development with private and public investment.

NEWS AND MEDIA

Ecological rescue mission for Mauritian reptiles affected by oil spill

September 16 2020 - Conservationists from Durrell Wildlife Conservation Trust, Mauritian Wildlife Foundation (MWF), BirdLife International, National Parks and Conservation Service of Mauritius (NPCS), and Forestry Service have enabled the emergency rescue of three species of rare reptiles, which might otherwise be facing extinction, following the Wakashio oil spill in Mauritius.  [...]

Landmark trial shows trained immunity reduces respiratory infections in the elderly by 80% 

September 1 2020
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Therapeutics, notes the results of a clinical trial1 (“the Trial”) published in Cell showing that trained immunity through the use of BCG vaccination can reduce respiratory tract infections by 80% amongst elderly people including, potentially, COVID-19. [...]

Jean Boulle Medtech’s New Therapeutics Technology Platform Targets Trained Immunity for COVID-19 Patients and Resultant Acute Respiratory Distress Syndrome

April 27 2020
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Medtech, is testing a unique strategy for treating Acute Respiratory Distress Syndrome1 (“ARDS”), which could prove to be highly effective in saving the lives of COVID–19 patients. [...]

HEAD OFFICE
25B Boulevard Royal
L2449 Luxembourg
Grand Duchy Luxembourg

CALL US
Tel: +352 222 512
Fax: +352 222 413

The Jean Boulle Group acquires promising assets and projects, then optimizes their structure, management and development with private and public investment.

Copyright © 2019 Jean Boulle Group. All rights reserved.